Status:
COMPLETED
An Innovative Silicone Wound Dressing for the Management of Atrophic Vaginitis
Lead Sponsor:
Stratpharma AG
Conditions:
Atrophic Vaginitis
Eligibility:
FEMALE
Phase:
NA
Brief Summary
The objective of the study is to determine the efficacy of 7-0940 in the management of atrophic vaginitis in female patients
Eligibility Criteria
Inclusion
- Able to provide informed consent
- Diagnosed acute or chronic Atrophic Vaginitis
- Controlled disease, or uncontrolled disease that did not respond to standard therapy with HRT
Exclusion
- Unable to provide informed consent
- Patient unable to apply topical device
- Allergy or intolerance to ingredients or excipients of the formulation of studied products
- Currently on HRT (orally or topically)
- Currently on corticosteroid treatment
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05432154
Start Date
April 1 2022
End Date
July 31 2022
Last Update
August 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Orange Coast Women's Medical Group
Laguna Hills, California, United States, 92653